Thirty patients (17 females, median age 55 years) with mild/moderate hypertension (sitting
diastolic blood pressure 95-110 mmHg over 2 consecutive weeks) participated in a study of …

The comparative effects of the once a day calcium channel antagonists amlodipine and long-
acting diltiazem were assessed in a parallel design, investigator-blinded, multicenter trial in …

Twelve patients with mild to moderate essential hypertension were included in a double-
blind, balanced, randomized placebo-controlled cross-over study to assess the efficacy and …

This randomized, double-blind, placebo-controlled, parallel-group study evaluated the
efficacy and safety of single daily dose diltiazem extended-release (XR) and indapamide …

The safety and effectiveness of a once daily formulation of diltiazem hydrochloride (diltiazem
CD) in the treatment of essential hypertension was assessed in a total of 127 patients with …

Objectives To compare the blood pressure effects of two dihydropyridine calcium channel
blockers, amlodipine and nitrendipine, in 488 patients with essential hypertension. Methods …

The objective was to evaluate the dose-related efficacy/tolerance profile of 240, 300, 360,
and 420 mg diltiazem slow-release, once-daily (OD) doses, with emphasis on the 300 mg …

The antihypertensive efficacy and safety of amlodipine was evaluated in an open,
multicenter general practice study. Hypertensive patients with sitting diastolic blood pressure …

The anti-hypertensive efficacy of once-daily amlodipine (up to 10 mg) and lisinopril (up to 20
mg) were compared in terms of clinic and ambulatory blood pressure (BP) control, in an …

A multicenter, randomized, placebo-controlled, parallel group study of diltiazem in essential
hypertension was carried out in 77 patients (40 difazem, 37 placebo) with stable supine …